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Brain gliomas require a deep knowledge of their effects on brain connectivity.
Understanding the complex relationship between tumor and functional brain is the
preliminary and fundamental step for the subsequent surgery. The extent of resection
(EOR) is an independent variable of surgical effectiveness and it correlates with the overall
survival. Until now, great efforts have been made to achieve gross total resection (GTR) as
the standard of care of brain tumor patients. However, high and low-grade gliomas have
an infiltrative behavior and peritumoral white matter is often infiltrated by tumoral cells.
According to these evidences, many efforts have been made to push the boundary of the
resection beyond the contrast-enhanced lesion core on T1w MRI, in the so called
supratotal resection (SpTR). SpTR is aimed to maximize the extent of resection and
thus the overall survival. SpTR of primary brain tumors is a feasible technique and its safety
is improved by intraoperative neuromonitoring and advanced neuroimaging. Only
transient cognitive impairments have been reported in SpTR patients compared to GTR
patients. Moreover, SpTR is related to a longer overall and progression-free survival along
with preserving neuro-cognitive functions and quality of life.
Keywords: supratotal resection, brain mapping, connectomics, brain connectome, high-grade gliomas, low-grade
gliomas, brain tumor, extent of resectionINTRODUCTION
Gliomas constitute a common type of primary brain tumor. Malignant histological subtypes (high-
grade gliomas, HGGs), are classified by the World Health Organization (WHO) as either grade III
or IV tumors. Glioblastoma (GBM) is the most common and aggressive malignant primary brain
tumor (1–7). It carries an unfavorable prognosis with a median overall survival of 12–18 months
and early death after diagnosis in case of no intervention (8–10). Currently, surgical interventionMarch 2021 | Volume 11 | Article 6458541
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documented that the extent of surgery has the key role in
affecting the patient overall survival (OS) (8, 10, 11).
Contrast-enhancement on brain MRI is commonly
considered a consequence of the blood-brain barrier (BBB)
permeabilization because of the tumor infiltrative behaviour;
consequently, the boundaries of contrast-enhancement on
brain MRI are considered to reflect the margins of the tumoral
lesion (10). In support of this assumption, the extent of resection
(EOR) of the tumoral lesion is independently correlated to
survival time. In facts, it has been reported that the resection
of more than 95% of the contrast-enhancement mass, or residual
tumor volume lower than 2 cm3 are independently associated
with improved OS and delayed recurrence (12). According to
these evidences, EOR has been assumed as a metric to judge the
success of tumor resection and to predict improved long-term
outcomes, such as progression-free survival (PFS) and OS (13):
in particular, lesser residual tumor volume is directly correlated
to longer OS (10).
Low grade gliomas (LGGs - WHO grade II) are less frequent
than HGGs; they are usually diagnosed in young adults with no
or mild neurological and neuropsychological impairments and
they are characterized by a better prognosis (12). Their growth is
characterized by gradual and slow infiltrating behaviour through
the adjacent brain tissue; The slow-growing pattern of LGGs
induces brain plasticity phenomena which may result in
functional compensation and may explain the lack of
detectable neurological impairments in LGGs (14).
A significant correlation between the EOR and the OS in
LGGs has been demonstrated by MRI-based volumetric studies
(12). Even if with lesser extent than HGGs, LGGs infiltrate the
adjacent normal-appearing brain parenchyma and tumor cells
have been found up to 20 mm beyond the area of MRI
pathological boundaries. According to this evidence, LGGs are
considered potential malignant tumors since the diagnosis, thus
early and aggressive surgical treatment is advised (12, 15).
Currently, the main purpose of LGGs treatment is to delay the
malignant transformation by reaching the supratotal resection of
normal-appearing but infiltrated brain parenchyma, in order to
increase patient OS and to preserve quality of life (QoL) (12, 16).
It has been clearly demonstrated that supratotal resection
positively influences the natural history of LGGs compared to
the only GTR which has been associated more frequently
to malignant transformation (12). Considering the easier access
to brain imaging and consequent earlier diagnosis, more patients
are discovered with incidentally and asymptomatic LGGs. In
these cases, preventive surgery may be considered legitimate for
the lower morbidity related to surgery, the higher rate of
successful supratotal resection and the strong impact on the
OS (12, 15, 17–21).
Nowadays, GBM is considered not only a highly proliferative
tumor with high rate of recurrence even after radical surgery (8),
but it should be also considered as a “diffuse disease of the brain”
migrating along the white matter tracts (18). In fact, it was
histologically demonstrated that tumoral cells may be found far
from the primary lesion, beyond the enhanced boundaries onFrontiers in Oncology | www.frontiersin.org 2T1-weighted brain MRI (22, 23). According to these evidences,
MRI imaging may underestimate the real extent of the tumor
(24); thus, a Gross Total Resection (GTR, defined as the removal
of the T1-weighted contrast-enhanced zone on brain MRI) of the
tumor may not be enough (13). Despite EOR up to 100% of the
contrast-enhanced tumor volume (10), it has been shown that
tumoral infiltration may be found within 2 to 3 cm from the
border of the original lesion (8), making tumor recurrences
inevitable and mostly located near the resection cavity (10).
Consequently, the infiltrative nature of GBM cells makes it
difficult to eliminate microscopic disease and macroscopic
GTR should not be considered a complete resection (8). In this
setting, research has gone so far to broaden the contribution of
gliomas surgery extending the concept of just a “tumorectomy”
(18). The concept of supramarginal resection has been developed
to describe the resection of the peritumoral tissue beyond the
distinctive enhanced tumor mass on T1-wheighet brain MRI,
with the aim to remove the microscopically infiltrated
surrounding brain parenchyma (10, 11).MATERIALS AND METHODS
An extensive systematic literature review was performed
according to PRISMA guidelines on PubMed, MEDLINE and
Scopus databases using the following keywords: “supratotal
resection”, “supramarginal resection” “supratotal resection
AND GTR” “supratotal resection AND connectomics”,
“supratotal resection AND brain mapping”, “supratotal
resection AND brain connectivity”, “supratotal resection AND
glioma”, “brain mapping AND glioma”. Meta-analyses, review,
clinical series and case reports were included. Non-English works
and studies lacking of full text were excluded. After the initial
identification, each article was screened according to the topic of
this review and only articles discussing the feasibility and
application of SpTR in brain gliomas were selected. Moreover,
pre- and intra-operative brain mapping techniques were
enlightened in order to clarify their application in case of
SpTR and their relationship with brain connectomics. Among
the selected articles, we included those concerning the concept of
connetome and brain connectomics, the role of SpTR for the
treatment of brain gliomas and the pre-operative and intra-
operative tools and techniques aimed to perform SpTR.RESULTS
Through a careful analysis of the literature, we obtained an
insightful review of the current applications of brain mapping-
aided SpTR for brain gliomas. From the first queries, 1924
unique records were identified. These records were screened
according to our above mentioned inclusion criteria; thus, 223
articles were identified and 137 articles were later excluded due to
the lack of full text or relevance according to the topic of this
review and our inclusion criteria. From the 86 full-text articles
assessed for eligibility, 16 more articles were excluded because ofMarch 2021 | Volume 11 | Article 645854
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SpTR. Finally, after a careful revision, we included in this
systematic review 70 articles (Figure 1).DISCUSSION
Brain Connectomics and SupraTotal
Resection (SpTR) of Brain Gliomas
During the last decade, the principle of locationism and the
distinction of eloquent areas have been replaced by the emerging
concept of brain “connectomics” (25). Connectomics is a novel
multidisciplinary paradigm in which the brain is seen as a
complex network of individual components interacting
through continuous communication (26). This paradigm
overcomes the former existence of eloquent areas and it relies
on the concept of “connectome”, which represents the
interconnection of every part of the brain through white
matter fibers (27).
According to this concept, focal and slow growth tumors
determine an upsetting of normal functional relations within the
brain, leading to an anatomical reshaping and functional
reconfiguration of both cortical and subcortical networks even
far beyond the tumor borders (26). Thus, the functional sequelae
of brain tumors should be considered also at a global level since
these functional changes influence whole-brain functionalFrontiers in Oncology | www.frontiersin.org 3complexity and network architecture (26, 28). Moreover, the
effects of tumor removal are related to the individual network
robustness since the removal of the surrounding peritumoral
brain might be functionally counterbalanced and might not
result in significant additional functional impairment (26).
This opens up the doors to the concept of onco-functional
balance. According to this, surgical resection is guided by pre-
operative assessment and intraoperative functional mapping and
it takes account of the considerable structural-functional
variability and the individual neural dynamics across glioma
patients, in order to significantly increase patient’s OS and to
decrease the rate of neurological impairments and the
consequent disability (17, 29). This rising concept paves the
way even for the treatment of tumors within brain structures
previously considered inoperable (17).
The adoption of supratotal resection (SpTR) is a further step
toward the treatment of brain gliomas. SpTR was firstly adopted
for the treatment of diffuse LGGs, taking advantage from the
reshaping of brain networks induced by neuroplasticity and
related to LGGs slower growth rate; then, SpTR has been also
adopted for the treatment of HGGs (12, 30).
It has been shown that the complete resection of T1w contrast
enhanced tumoral tissue together with the resection of more than
53,21% of the surrounding T2-weighted fluid-attenuated
inversion recovery (FLAIR) abnormalities is associated whit a
longer OS, than in case of less extensive resection (12, 31). TheFIGURE 1 | Flow-diagram of the results of this systematic review according to PRISMA statement.March 2021 | Volume 11 | Article 645854
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volume as boundaries of tumor resection but it tends toward a
maximal resection of the T2/FLAIR signal abnormalities (18).
Obviously, an extensive tumor resection could dramatically
increase the risk of neurological deterioration and negative
influence on patient OS (10). Thus, actual preservation of
neurological function and maintenance of QoL are being
actively pursued as a fundamental aspect of treating patients
with gliomas, and improvement in QoL is considered to be an
integral part for determining OS (1). This reveal a fundamental
change from the idea of a surgery related to anatomical
boundaries to the idea of a surgery guided by functional
boundaries (18). The aim of this new surgical concept is to
safely push the boundaries of surgical resection through FLAIR
abnormalities under the guidance of functional brain-mapping
until eloquent structures have been encountered. This type
of functional guidance relies on an accurate study of the
individual brain functional anatomy, intraoperative mapping
through cortical and sub-cortical electrical stimulation,
neurophysiological monitoring, and intraoperative imaging
guidance (32, 33). This underlines the importance of safest
surgical resection possible according not only to anatomical
but also to functional boundaries. Since the OS is directly
related to the EOR, SpTR may be taken into account not only
in case of involvement of non-eloquent structures but also when
a mild neurological impairment with few consequences on daily
life is an acceptable price to pay for the patient in order to
prolong OS while attending a neurological recover (18).
Pre-Operative Evaluation, Functional
Imaging, and Cognitive Assessment
A careful preoperative selection of patients who can benefit from
surgery is mandatory in order to meet the most favorable onco-
functional balance (17).
Pre-operative imaging technique is accomplished MRI using
different and specific sequences (34). Functional MRI (fMRI)
plays a key role for the identification of motor cortex and
language dominance through the evaluation of regional blood
flow (BOLD or blood-oxygen-level dependent) changes, thus
contributing to the analysis of connectome (35). Two different
types of fMRI could be performed: task-based fMRI and task-free
resting state fMRI. Since the execution of repetitive tasks could
create artifacts in the evaluation of BOLD signals, resting-state
fMRI is considered a more reliable mapping technique in pre-
operative surgical planning (36). However, fMRI reliability is
influenced by perfusion changes induced by different gliomas
(37), in particular in HGGs (38).
Diffusion Tensor Imaging (DTI) and Diffusion Tensor
Tractography (DTT) represent two MRI techniques which are
capable to depict subcortical white matter tracts. DTI relies on
evaluation of diffusion tensor basing on diffusion indexes of
water molecules. Starting from DTI, DTT is employed to depict
subcortical neural networks basing on the orientation of axonal
bundles according to their anisotropy; this technique shows the
capability to depict white matter tracts through the direction of
water molecules, to identify signal anomalies and axonal integrityFrontiers in Oncology | www.frontiersin.org 4(39). Unfortunately, DTI is prone to distortions during
computation of fiber-tracking algorithm (40). However, DTT
is a useful preoperative tool for tridimensional representation
of the fiber tracts capable to influence the surgical strategy;
moreover , more complex DTI process ing and the
corroboration of intraoperative monitoring such ash Direct
Electrical Stimulation (DES) may overcome DTI limitations
thus allowing a precise functional evaluation and estimation of
EOR in glioma patients (39, 40).
Recently, functional neuroimaging (fMRI, DTI, DTT) has
been being supported by navigated transcranial magnetic
stimulation (nTMS). Through nTMS it is possible to accurately
map eloquent and motor areas using magnetic stimulation.
nTMS can significantly reduce surgical time and guarantee a
better functional outcome if coupled intraoperatively with DES
(41). fMRI, nTMS, and DES guarantee a continuous control of
motor, sensory or language domains on awake patients, thus
ensuring a more radical excision according to functional
boundaries (42).
Besides functional imaging, neuropsychological assessment
plays a key-role in the pre-operative functional evaluation.
Through the administration of several different tasks it is
possible to gather information about patients’ cognitive pre-
operative status and to diagnose functional impairments about
information processing speed, attention, working memory,
verbal memory, visual memory, executive and phasic functions
(43, 44). In order to perform a standardized neuropsychological
assessment several tests have been developed and validated to
explore several neurological domains; some of them can also be
run on a friendly and common device such an iPad (45–50).
Intraoperative Monitoring and Surgical
Technique During Brain Mapping-Guided
SpTR
Onco-functional balance represents the crucial node of SpTR in
order to obtain the maximal feasible resection without
unrecoverable functional impairments (12). For this purpose, a
novel surgical perspective which relies on integrated preoperative
and intraoperative functional evaluation is demanded (12,
30, 51).
Feasibility of SpTR is related to some functional and technical
issues. Firstly, surgical resection extended beyond contrast-
enhanced tumoral margins on T1-w MRI could interfere with
the functionality of neighbouring eloquent areas. Secondly,
infiltrated brain tissue with low density of tumoral cells could
not be correctly discriminated by normal brain tissue, leading to
partial or non-complete resection (10, 52, 53). In order to achieve
SpTR while preserving neurological functions, image-guided
surgery must be overtaken and replaced by a functional-guided
surgery (12).
The most reliable intraoperative method to directly identify
functional neural networks is intraoperative DES during awake
surgery. DES uses a biphasic electrical current to generate direct
transient stimulation or interference within cortical or
subcortical networks (54). DES could be associated by
intraoperative sensorimotor localization, which relies on phaseMarch 2021 | Volume 11 | Article 645854
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transition between sensitive and motor cortex through the
registration of somatosensory evoked potential (SSEP)
electrical phase (54).
Usually, intraoperative functional mapping through
electrostimulation is performed during staged “asleep-awake-
asleep” surgery (55). In the first stage, cortical areas are exposed
and local markers are placed along the tumor borders before
surgical manipulation. Functional areas are detected through
neuronavigation on former functional brain imaging and
through DES. During the second stage, the patient is
awakened. Basing on preoperative functional assessment,
patient undergoes selective tasks related to the tumor
localization; during tasks execution, surgeon simultaneously
apply DES on peritumoral areas in order to evoke incorrect or
inappropriate neurological response if functional network is
stimulated (25, 45). During this stage, DES is alternated to
tumor excision in order to identify functional boundaries
which will limit the resection; then, the patient is asleep in
order to perform haemostasis and closure (55, 56). During the
whole procedure, somatosensory and motor evoked potentials
are recorded and continuous electrocorticograms is performed to
detect discharge phenomena during direct brain stimulation and
tumor resection (45).
This surgical technique allows surgeon to remove non-
functional areas within a functional “security boundary” and to
obtain greater EOR without an increased risk of permanent
neurological impairments (12, 55). According to this evidence,
tumor resection may be extended even to eloquent networks in
order to optimize the “onco-functional” balance (57).
Brain mapping techniques have demonstrated increased rates
of SpTR and a subsequent increased OS, especially in LGGs (22,
25, 32, 54, 55, 58). Intraoperative DES in awake patients allows a
dramatic decrease in permanent neurological impairment, while
increasing transient ones which are mostly recoverable (54, 55).
On the other hand, surgical strategy for resection of HGGs
should be more tailored on an accurate balance between EOR
and preservation of cognitive functions since the short time for
neurological recovery before the mandatory postoperative
treatments (radio- and chemo-therapy) (16, 59).
Anatomical boundaries of gliomas during surgical resection
may be enlightened by the use of fluorophores such as 5-
aminolevulinic acid (5-ALA) and sodium fluorescein,
intraoperative MRI (iMRI) and intraoperative ultrasoundFrontiers in Oncology | www.frontiersin.org 5(IOUS) in order to verify the extent of resection (10, 30, 51,
60–66). iMRI with integrated functional neuronavigation is
commonly used to achieve better visualization of residual
tumor volume and to reassess neuronavigation during surgical
manipulation to overcome brain shift (60, 67). As an adjunct,
IOUS with our without contrast enhancement (CEUS) is a
valuable tools to distinguish tumoral tissue from normal brain
parenchyma; notably, IOUS is more accessible than iMRI and it
immediately allows a real-time visualization of tumoral tissue
during surgical manipulation (68). As regards fluorescent dyes,
5-ALA is specifically accumulated by glioma cells and it is
enlightened by intraoperative source of blue-light (10, 52, 53,
69). The use of fluorescent dyes with neuronavigation guarantees
greater EOR than the only neuronavigation. The maximum rate
of resection could be achieved by combining fluorescent dyes and
neuronavigation into the “dual intraoperative visualization
approach” (DiVA), which permits further improvement in
EOR and a consequent prolonged OS (10, 30, 51, 61, 62, 70).CONCLUSIONS
Despite extended surgical resection, LGGs and HGGs are still
burdened by the possibility of tumor recurrence. Specific
selection criteria are needed before surgery in order to achieve
the best possible result in removing safely the maximum of
infiltrated brain tissue beyond tumoral margins. SpTR represents
a novel concept of glioma surgery which relies on the evaluation
of brain connectomics. SpTR reflects the effort to reach the best
oncological outcome while preventing any permanent
neurological and/or cognitive postoperative impairment, thus
preserving patient’s QoL and accordingly increasing OS.AUTHOR CONTRIBUTIONS
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